chlorzoxazone has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 4 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marinina, KS | 1 |
| Bezprozvanny, IB | 3 |
| Egorova, PA | 3 |
| Bushart, DD | 1 |
| Huang, H | 1 |
| Man, LJ | 1 |
| Morrison, LM | 1 |
| Shakkottai, VG | 1 |
| Gavrilova, AV | 1 |
| Zakharova, OA | 1 |
| Vlasova, OL | 1 |
4 other studies available for chlorzoxazone and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
A chlorzoxazone-folic acid combination improves cognitive affective decline in SCA2-58Q mice.
Topics: Animals; Chlorzoxazone; Cognition; Cognitive Dysfunction; Mice; Mice, Transgenic; Spinocerebellar At | 2023 |
A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.
Topics: Animals; Ataxin-1; Baclofen; Calcium Channels, T-Type; Cerebellum; Chlorzoxazone; Disease Models, An | 2021 |
In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2.
Topics: Action Potentials; Aging; Animals; Cerebellum; Chlorzoxazone; Disease Models, Animal; Injections, In | 2021 |
In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Topics: 1-Naphthylamine; Action Potentials; Aging; Animals; Chlorzoxazone; Disease Models, Animal; Injection | 2016 |